Hypercholesterolemia
📧 Sign up to get email alerts when something new happens for Hypercholesterolemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-07-20FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Biocon Pharma Inc.)
FDA issued a supplemental approval for atorvastatin calcium from Biocon Pharma Inc. under an ANDA.
-
CLINICAL_TRIALS trial_result · 2023-07-17Clinical Trial Update: Efficacy and Safety Study of Pitavastatin for Hypercholesterolemia [Phase 3]
Phase 3 trial update on pitavastatin for hypercholesterolemia with posted results.
-
FDA approval · 2023-07-14FDA Approved: ROSUVASTATIN CALCIUM — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for rosuvastatin calcium (rosuvastatin) from Ascend Laboratories, LLC.
-
FDA approval · 2023-07-13FDA Approved: ROSUVASTATIN CALCIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for ROSUVASTATIN CALCIUM from Torrent Pharmaceuticals Limited, confirming regulatory approval for th…
-
FDA approval · 2023-07-13FDA Approved: ROSUVASTATIN CALCIUM — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries' supplemental ANDA for rosuvastatin calcium, a generic rosuvastatin salt product.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-06-30FDA Approved: COLESEVELAM HYDROCHLORIDE — Supplemental Application (Dr.Reddys Laboratories Inc)
FDA approved a supplemental application for Colesevelam hydrochloride by Dr. Reddy's Laboratories, approving a generic version of the choles…
-
CLINICAL_TRIALS trial_result · 2023-05-25Clinical Trial Update: Supplements, Placebo, or Rosuvastatin Study [Phase 2]
Phase 2 clinical trial update for a rosuvastatin-related study in adults with hypercholesterolemia; results have been posted.
-
CLINICAL_TRIALS trial_result · 2023-05-19Clinical Trial Update: Study of SHR-1209 in the Treatment of Hypercholesterolemia and Hyperlipidemia Ⅲ Stage [Phase 3]
Phase 3 clinical trial studying SHR-1209 for primary hypercholesterolemia and mixed hyperlipidemia has completed.
-
CLINICAL_TRIALS trial_result · 2023-05-10Clinical Trial Update: Study of Efficacy and Safety of Inclisiran in Japanese Participants With High Cardiovascular Risk and Elevated LDL-C [Phase 2]
This Phase 2 study evaluated the efficacy and safety of Inclisiran in Japanese participants at high cardiovascular risk with elevated LDL-C.…
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia [Phase 3]
Phase 3 trial update of alirocumab in children and adolescents with heterozygous familial hypercholesterolemia; study completed with results…
-
FDA approval · 2023-04-25FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for atorvastatin calcium submitted by Dr. Reddy's Laboratories Limited.
-
CLINICAL_TRIALS trial_result · 2023-04-25Clinical Trial Update: SHR - 1209 Treatment Efficacy and Safety of the Patients With Hypercholesterolemia Ⅲ Period Clinical Research [Phase 3]
Phase 3 trial update assessing efficacy and safety of SHR-1209 for primary hypercholesterolemia; study completed.
-
CLINICAL_TRIALS trial_result · 2023-04-04Clinical Trial Update: Evaluation of ETC-1002 in Participants With Hypercholesterolemia and Hypertension [Phase 2]
Phase 2 trial evaluating ETC-1002 in people with high cholesterol and high blood pressure has completed; results posted.
-
CLINICAL_TRIALS trial_result · 2023-03-29Clinical Trial Update: Trial to Evaluate Efficacy and Safety of LIB003, Evolocumab and Alirocumab in High-risk CVD Patients [Phase 3]
Phase 3 trial evaluating LIB003 with Evolocumab and Alirocumab in high-risk cardiovascular disease patients has completed.
-
CLINICAL_TRIALS trial_result · 2023-03-15Clinical Trial Update: The Efficacy and Safety of JS002 PFS and AI in Patients With Primary Hypercholesterolemia and Mixed Hyperlipidemia [Phase 3]
Phase 3 trial evaluating the efficacy and safety of JS002 for primary hypercholesterolemia and mixed hyperlipidemia has completed.
-
CLINICAL_TRIALS trial_result · 2023-03-15Clinical Trial Update: Open-Label Study To Evaluate MN-001 on HDL & Triglyceride in NASH & NAFLD Subjects [Phase 2]
Phase 2 open-label trial evaluating MN-001 on HDL and triglycerides in subjects with NASH/NAFLD completed with results posted.
-
FDA approval · 2023-03-10FDA Approved: COLESTIPOL HYDROCHLORIDE — Original Application (ANI Pharmaceuticals, Inc.)
FDA approved ANI Pharmaceuticals' original-application approval for Colestipol hydrochloride, a generic cholesterol-lowering medicine used t…
-
CLINICAL_TRIALS trial_result · 2023-03-03Clinical Trial Update: A Multiple Ascending Dose Study of HTD1801 in Adults With Hypercholesterolemia [Phase 1, Phase 2]
Phase 1/2 multiple ascending dose study in adults with hypercholesterolemia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-03-02Clinical Trial Update: A Study of PCSK9 Inhibitor AK102 in Patients With Hypercholesterolemia [Phase 2]
Phase 2 trial update for AK102, a PCSK9 inhibitor, in patients with hypercholesterolemia; study completed.
-
CLINICAL_TRIALS trial_result · 2023-03-02Clinical Trial Update: A Long-term Study of AK102 in Patients With Hypercholesterolemia [Phase 2]
Phase 2 long-term study update of AK102 in patients with hypercholesterolemia has completed.
-
CLINICAL_TRIALS trial_result · 2023-02-10Clinical Trial Update: Study of Evinacumab (REGN1500) in Participants With Persistent Hypercholesterolemia [Phase 2]
A Phase 2 clinical trial of evinacumab (REGN1500) in participants with persistent hypercholesterolemia has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Ezetimibe (EZ)/Atorvastatin (Ator) (MK-0653C) vs. Ator in Chinese Hypercholesterolemic Participants (MK-0653C-439) [Phase 3]
Phase 3 trial comparing ezetimibe/atorvastatin (MK-0653C) versus atorvastatin alone in Chinese participants with hypercholesterolemia. Resul…
-
CLINICAL_TRIALS trial_result · 2022-12-20Clinical Trial Update: A Clinical Trial to Evaluate the Efficacy and Safety of CKD-391 and CKD-331 in Patients With Primary Hypercholesterolemia [Phase 3]
A Phase 3 trial evaluating CKD-391 and CKD-331 for primary hypercholesterolemia is ongoing with unknown status.
-
FDA approval · 2022-11-23FDA Approved: ATORVASTATIN CALCIUM — Original Application (Biocon Pharma Inc.)
FDA approval of Biocon Pharma Inc.'s atorvastatin calcium as an original generic application (ANDA) aligned to the reference product labelin…
-
FDA approval · 2022-11-03FDA Approved: ATORVASTATIN CALCIUM — Original Application (Lepu Pharmaceutical Technology Co., Ltd.)
FDA approves the original application for atorvastatin calcium (generic) from Lepu Pharmaceutical Technology Co., Ltd. The approval adds a g…